BANK OF MONTREAL /CAN/ - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 87 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$6,000
-71.4%
536
-73.6%
0.00%
Q1 2021$21,000
-88.3%
2,034
-81.7%
0.00%
Q4 2020$179,000
+280.9%
11,112
+241.3%
0.00%
Q3 2020$47,000
-82.3%
3,256
-76.9%
0.00%
Q2 2020$266,000
+83.4%
14,100
+86.5%
0.00%
Q4 2019$145,000
+190.0%
7,559
+46.7%
0.00%
Q3 2019$50,000
+72.4%
5,154
+8.1%
0.00%
Q2 2019$29,000
+383.3%
4,770
+599.4%
0.00%
Q4 2018$6,0000.0%682
+103.6%
0.00%
Q3 2018$6,0000.0%335
-2.6%
0.00%
Q2 2018$6,000
-95.9%
344
-97.9%
0.00%
Q2 2017$148,000
-29.5%
16,3180.0%0.00%
Q1 2017$210,000
+39.1%
16,3180.0%0.00%
Q4 2016$151,000
-5.0%
16,3180.0%0.00%
Q3 2016$159,000
+5200.0%
16,318
+5469.3%
0.00%
Q1 2016$3,000
-50.0%
293
-32.3%
0.00%
Q4 2015$6,000
+500.0%
433
+397.7%
0.00%
Q3 2015$1,000
-50.0%
87
+17.6%
0.00%
Q2 2015$2,0000.0%740.0%0.00%
Q1 2015$2,000
-33.3%
740.0%0.00%
Q4 2014$3,000
-66.7%
74
-63.0%
0.00%
Q2 2014$9,0002000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$13,170,0009.51%
Palo Alto Investors LP 5,383,052$31,329,0001.89%
Birchview Capital, LP 246,000$1,432,0000.97%
Rubric Capital Management LP 3,375,758$19,647,0000.55%
Lombard Odier Asset Management (Switzerland) SA 1,517,804$8,834,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 1,401,861$8,159,0000.30%
AlphaCentric Advisors LLC 136,000$792,0000.20%
Bridgefront Capital, LLC 20,946$122,0000.13%
Hennion & Walsh Asset Management, Inc. 407,474$2,371,0000.12%
Virtus ETF Advisers LLC 44,364$258,0000.11%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders